Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 39% ± 23% | |
GABAergic neuron | 4 studies | 29% ± 12% | |
type I pneumocyte | 3 studies | 21% ± 4% | |
granule cell | 3 studies | 29% ± 8% | |
interneuron | 3 studies | 28% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 37% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 596.85 | 240 / 245 | 97% | 7.99 | 486 / 502 |
pancreas | 100% | 692.85 | 327 / 328 | 85% | 5.84 | 151 / 178 |
lung | 89% | 490.85 | 514 / 578 | 89% | 11.41 | 1032 / 1155 |
thymus | 81% | 249.93 | 531 / 653 | 92% | 7.84 | 556 / 605 |
bladder | 86% | 417.38 | 18 / 21 | 80% | 9.58 | 403 / 504 |
intestine | 55% | 270.72 | 530 / 966 | 94% | 19.81 | 495 / 527 |
uterus | 66% | 473.49 | 113 / 170 | 82% | 7.96 | 376 / 459 |
brain | 93% | 1360.44 | 2465 / 2642 | 42% | 2.48 | 295 / 705 |
esophagus | 41% | 140.67 | 592 / 1445 | 89% | 12.53 | 163 / 183 |
stomach | 39% | 153.08 | 139 / 359 | 86% | 14.89 | 246 / 286 |
muscle | 100% | 21069.64 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.28 | 1 / 1 |
breast | 17% | 52.31 | 79 / 459 | 78% | 8.04 | 874 / 1118 |
heart | 95% | 1022.56 | 816 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.66 | 39 / 45 |
skin | 11% | 34.34 | 200 / 1809 | 48% | 4.39 | 225 / 472 |
kidney | 38% | 99.54 | 34 / 89 | 20% | 0.98 | 182 / 901 |
ovary | 2% | 6.02 | 4 / 180 | 54% | 2.17 | 232 / 430 |
eye | 0% | 0 | 0 / 0 | 45% | 2.72 | 36 / 80 |
adrenal gland | 4% | 15.47 | 11 / 258 | 28% | 1.32 | 65 / 230 |
blood vessel | 28% | 107.23 | 378 / 1335 | 0% | 0 | 0 / 0 |
liver | 8% | 24.31 | 18 / 226 | 17% | 0.89 | 71 / 406 |
adipose | 4% | 9.78 | 45 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
peripheral blood | 1% | 4.41 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0060402 | Biological process | calcium ion transport into cytosol |
GO_0060314 | Biological process | regulation of ryanodine-sensitive calcium-release channel activity |
GO_0007517 | Biological process | muscle organ development |
GO_0014701 | Cellular component | junctional sarcoplasmic reticulum membrane |
GO_0030314 | Cellular component | junctional membrane complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030018 | Cellular component | Z disc |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008307 | Molecular function | structural constituent of muscle |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | JPH1 |
Protein name | Junctophilin-1 (JP-1) (Junctophilin type 1) JPH1 protein Junctophilin 1 |
Synonyms | JP1 |
Description | FUNCTION: Junctophilins contribute to the formation of junctional membrane complexes (JMCs) which link the plasma membrane with the endoplasmic or sarcoplasmic reticulum in excitable cells. Provides a structural foundation for functional cross-talk between the cell surface and intracellular calcium release channels. JPH1 contributes to the construction of the skeletal muscle triad by linking the t-tubule (transverse-tubule) and SR (sarcoplasmic reticulum) membranes. |
Accessions | ENST00000519947.1 Q4KMX3 Q86VR1 Q9HDC5 ENST00000342232.5 E5RHU9 |